A Multicomponent Exercise Medicine Programme in Patients with Pancreatic Cancer Undergoing Neoadjuvant Therapy (the EXPAN trial): A Two-armed Phase I Randomised Controlled Trial, National Health and Medical Research Council, MRFF - Clinical Trials Activity (Rare Cancers, Rare Diseases and Unmet Need) Initiative, 2022-2026, $561,910.
Prostate Cancer Survivorship Essentials for Men with Prostate Cancer on Androgen Deprivation Therapy: Transforming Care to Improve Outcomes, National Health and Medical Research Council Partnership Project Grant, 2021, $2,250,000.
Australasian Malignant Pleural Effusion (AMPLE)-3 trial, National Health and Medical Research Council, Clinical trials and cohort studies, 2021-2025.
Weight loss for overweight and obese prostate cancer patients: a randomised trial of a clinic-based versus telehealth delivered exercise and nutrition intervention. Cancer Council of WA. 2021. $472,738
Physical health during isolation, including chronic disease progression in older West Australians. Department of Jobs, Tourism, Science and Innovation/Covid-19 Research Fund. 2021. $100,000
Medical and Health Research Infrastructure Fund (MHRIF). 2021. $44,268.
Exercise as adjuvant therapy to increase prostate tumour oxygenation and improve effectiveness of radiotherapy. Cancer Council Western Australia, Project Grant, 2020-2021, $94,449.
Physical health during isolation, including chronic disease progression inn older West Australians. Department of Jobs, Tourism, Science and Innovation/Covid-19 Research Fund, 2020-2022, $100,000.
Muscle morphology and function in women with advanced-stage ovarian cancer: Response to exercise medicine and implications for treatment, Cancer Council of WA Inc, PhD Top Up Scholarship, 2019 - 2021, $30,000.
Examining the efffect of creatine supplementation in augmenting adaptions to resistance training in prostate cancer patients undergoing androgen deprivation therapy: a randomised, double-blind, placebo controlled trial. Cancer Council of WA Inc/Collaborative Cancer Grant Scheme, 2019 - 2020, $50,000.
Medical and Health Research Infrastructure Fund 2018 (Round 22), Department of Health WA, Medical and Health Research Infrastructure, 2019 - 2020, $37,246.
Can exercise delay transition to active therapy in men with low grade prostate cancer? A multi-rnadomized controlled trial. National Health and Medical Research Council, Project Grant, 2018-2023, $596,084.
Cancer Council Postdoctoral Fellowship, 2018-2020. $150,000.
Exercise medicine for advanced cancer patients: improving survivorship and survival. Cancer Council Western Australia Postdoctoral Research Fellowship. 2017-2020. $240,000.
Feasibility and efficacy of dosing exercise medicine immediately before or after chemotherapy infusion, ECU Industry Collaboration Grant 2018–2020. $135,247.
Feasibility study of a brief, nurse-led behaviour change intervention to increase physical activity for prostate cancer survivors living in disadvantaged communities. World Cancer Research Fund International. 2019. £59,776.
Examining the effect of creatine supplementation in augmenting adaptations to resistance training in prostate cancer patients undergoing androgen deprivation therapy: a randomised, double-blind, placebo controlled trial. Cancer Council of WA. Collaborative Cancer Grant Scheme. 2019-2020. $64,560.
An exploratory study to determine if exercise can impact the gut microbiota composition of men receiving androgen suppression therapy for prostate cancer. Prostate Cancer Foundation of Australia, 2018-2020. $99,000.
Low bone mineral density in people with chronic obstructive pulmonary disease: a novel intervention to tackle this highly prevalent comorbid condition. Amgen OA-ANZBMS Clinical Grants Program, 2018-2020. $37,244.
A mixed methods investigation examining factors contributing to adherence on active surveillance. ANZUP Clinical Trials Group Limited. 2018-2019. $29,275.
The effect of cognitive and exercise training on Brain Atrophy and Cognitive Decline in Breast Cancer Patients Treated with Adjuvant Chemotherapy Agents. Cancer Council of Western Australia. Collaborative Cancer Grant Scheme. 2018. $49,966.
Supervised exercise program versus a home exercise program for cancer patients, prior to undergoing prostate surgery. Suzanne Cavanagh Early Career Investigator Grant. 2018 $35,000.
Centre for Research Excellence (CRE) Prostate Cancer Survivorship, National Health and Medical Research Council NHMRC 2017-2021.$2,498,842.
Exercise Medicine Prior to Open Radical Cystectomy: Feasibility and Preliminary Efficacy. ANZUP Clinical Trials Group Limited, Below the Belt Research Fund. 2017-2018, $50,000.
Development and preliminary evaluation of a web-based physical activity guidance tool for men with metastatic prostate cancer. ANZUP Clinical Trials Group Limited, Below the Belt Research Fund. 2017-2018, $47,000.
Department of Health. Government of Western Australia.Medical and Health Research Infrastructure Fund (MHRIF) Round 20. $21,131.
Feasibility and efficacy of dosing exercise medicine immediately before or after chemotherapy infusion, Edith Cowan University, ECU Industry Collaboration Grant - 2017 Open Round. 2017-2018. $112,747.
Intense Exercise for survival among men with metastatic castrate-resistant prostate cancer. A multicentre, randomised controlled. phase 111 study. Movember Foundation, 2016-2024, $635,910.
Movember Foundation, GAP4 Exercise and Metabolic Health Trial - Exercise Central Coordinating Centre. 2016-2022, $395,726.
GAP4 Exercise and Metabolic Health Trial - Exercise Central Coordinating Centre, Movember Foundation Australia, Movember - GAP4 Prostate Cancer Exercise and Metabolic Health, 2016 – 2021. $342,985.
INTense Exercise foR surVivAL among men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL MCRPC): A Multicentre, Randomized, Controlled, Phase III Study, The Movember Group, Movember - GAP4 Prostate Cancer Exercise and Metabolic Health, 2016 – 2018. $290,544.
Allied Health Workforce Survey. Department of Health WA. 2016-2017. $61,098.
NTrueNTH solutions: an integrated multi-component intervention to improve the lives of men with prostate cancer in Australia - Demonstration of the Lifestyle and Exercise Program, The Movember Group, True NTH, 2016 – 2017. $140,380.
Mechanical modulation of bone metastases in advanced breast cancer patients: Can targeted exercise suppress osteolytic tumour progression? National Breast Cancer Foundation, Pilot Study Grant, 2016-2017 $184,300.
Mechanical modulation of bone metastases in advanced prostate cancer patients: Can targeted exercise suppress sclerotic tumour progression? A pilot study. Exercise & Sports Science Australia, Clinical Exercise Physiology Research Grant, 2015 – 2016. $37,200.
Exercise medicine for all cancer survivors: Implementation and evaluation of a national intervention program. Cancer Council of Western Australia – Research Project Grant. 2015. $100,000.
Preliminary Efficacy of Implementing a Program of Exercise Medicine for Men on Prostate Cancer Active Surveillance - A Pilot Study ECU Capability Enhancement Scheme 2015 $9,454.
Spinal Cord Injuries Australia, Spinal Cord Injury Collaborative Research Program: A partnership between Spinal Cord Injuries Australia and Edith Cowan University. 2014-Present $1,042,080.
National Health and Medical Research Council, Project Grant, 2014-2019, $565,380.
Improving health outcomes after cancer through exercise: a survivorship program. Cancer Council Western Australia Research Fellowship. 2014-2017. $320,000.
Improving sexual health in men with prostate cancer: randomized controlled trial of exercise and psychosexual therapies. National Health and Medical Research Council (NHMRC) Project Grant, 2014-2017. $561,845.
National Health and Medical Research Council (NHMRC) Equipment Grant 2013. $10,735.
Exercise as Medicine for Men with Prostate Cancer in Hong Kong. Movember Hong Kong. 2014. $64,792
Care Component: Lifestyle Exercise Prescription for Prostate Cancer. Movember Foundation Australia/Australian Survivorship Action Plan. 2014. $104,00.
Data Collection Services to the Epidemiology Branch, WA Department of Health. 2013-2018. $3,200,000.
Australian Lung Foundation/Bantoft Family Bequest. 2013-2016. $54,000.
Predicting optimal cancer rehabilitation and supportive care (POLARIS Study) Alpe d'HuZes/KWF foundation. 2013-2016. $1,290,000.
Can Appropriate exercise prevent declines in prostate cancer patients more effectively than rehabilitation following treatment toxicities? Cancer Australia, Priority Driven Collaborative Cancer Research Scheme Grants Commencing 2012-2014; $446,276.
Efficacy and Safety of a Modular Multi-modal Exercise Program in Prostate Cancer Patients with Bone Metastases: A Randomized Controlled Trial. 2012-2013. $296,820.
Whole-Body Vibration Treatment in Breast Cancer Survivors on Aromatase Inhibitor Therapy. Cancer Council of Western Australia. 2012-2013. $24,850.
Actigraph Physical Activity Monitoring System. Prostate Cancer Foundation of Australia – Equipment Grant; 2012. $33,000
Efficacy of an Oncologist Recommended Exercise Program on Cancer Related Fatigue in Breast Cancer Patients Undergoing Radical Radiotherapy. Edith Cowan University Early Career Research Grant. 2012. $25,000.
Exercise and Nutrition Intervention for Patient’s with Psoriasis. AbbVie Pty Ltd. 2012. $175,369
Exercise is Medicine. Australian Federal Government’s Collaborative Research Networks (CRN) program. 2011-2014. $988,188.
Exercise as Medicine for Cancer. The Cancer Council of Western Australia. 2011-2014. $225,000.
Exercise Training to Improve Physical Functioning and Exercise Adoption in Lung Cancer Survivors: a Randomized Controlled Trial. 2011-2012. $24,960.
Whole-Body Vibration Treatment in Prostate Cancer Survivors on Androgen Suppression Therapy. Australian Unity Heritage Fellowship. 2012-2013. $54,439.
Proscan for Life: A Multimodal Supportive Care Intervention for Men with Prostate Cancer. Cancer Australia/Beyond Blue. 2011-2013. $598,194.
The Feasibility and Preliminary Efficacy of a Distance-Based Physical Activity Intervention for Rural Lung Survivors. Edith Cowan University Faculty Early Career Research Grant. 2011. $9,022.
Equipment Grant pQCT XCT 3000 Clinical. Prostate Cancer Foundation of Australia. 2011. $80,000.
Efficacy and Safety of High Versus Low Intensity Resistance Exercise, with and without Compression for Management of Lymphoedema in Breast Cancer Survivors. Cancer Council of Western Australia and Cancer Council of Queensland Project Grant. 2011. $102,000.
Feasibility and Efficacy of Resistance Exercise in Prostate Cancer Survivors with Bone Metastases. 2011. $25,080.
Exercise for the Management of Lymphoedema in Breast Cancer Survivors. University of Canberra, DVCR Research Fellowship. 2011. $21,923.
Population-based Exercise Intervention for Prostate Cancer Patients – RADAR. Prostate Cancer Foundation of Australia. 2009-2012. $476.024.
A Phase III Clinical Trial of Exercise Modalities on Treatment Side-effects in Men Receiving Therapy for Prostate Cancer. National Health and Medical Research Council (NHMRC) Project Grant. 2009-2011. $500.000.
Lucrin Exercise Support Program. Abbott Australasia Pty Ltd. 2009. $50.600
Lucrin Immediate Exercise Trial. Abbott Australasia Pty Ltd. $170.000
A Randomized Controlled Trial of Exercise to Reduce Co-morbidity in Men Receiving Therapy for Prostate Cancer. Prostate Cancer Foundation of Australia. 2007-2010. $244.328.
A Randomized Controlled Trial of Exercise to Reduce Treatment Side-effects in Men Receiving Therapy for Prostate Cancer. The Cancer Council Western Australia. Amount. 2008. $70.000.
A Randomized Controlled Trial of Exercise to Reduce Treatment Side-effects in Men Receiving Therapy for Prostate Cancer. The Cancer Council of Queensland. 2008. $41.247.
Edith Cowan University - Research Infrastructure Block Grant. 2008. $82.316.
Resistance and Aerobic Exercise for Reducing Treatment Side-effects in Men Receiving ADT for Prostate Cancer. 2007. $24.600.
Resistance Training in Men Receiving Androgen Deprivation Therapy for Prostate Cancer. 2004-2005. $7,000.